LUCYNA PUSZKARSKA: Open Payments
NPI 1215035902 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 11 payments from 6 companies in 2025. Trend: 2023 $291 · 2024 $93 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $71 |
| ABBVIE INC. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, COBENFY, VRAYLAR, Auvelity, INGREZZA, REXULTI.
Industry payments across IL — which companies pay providers there.
